Amylyx Pharmaceuticals

Forecast & Rating12 analysts currently cover Amylyx Pharmaceuticals, with about 91.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $42.18, about 8.5% upside from the current price of $38.86. Price targets range from $20.00 to $55.00 — a wide spread, showing clear disagreement over just how much Amylyx Pharmaceuticals can rise. Historically, about 49.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Amylyx Pharmaceuticals closely still see room for the stock to rise. Data as of Aug 19, 2026; for reference only and not investment advice.